Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
38373
CAS Number:
138982-67-9
Clorhidrato de ziprasidona monohidrato
Purity:
≥ 98 % (HPLC)
Synonym(s):
Clorhidrato de 5-[2-[4-(1,2-bencisotiazol-3-il)-1-piperazinil]etil]-6-cloro-1,3-dihidro-2 H -indol-2-ona monohidrato
Documents
$56.99 /50 mg
Tamaño
Request Bulk Quote
Información del producto

Ziprasidone hydrochloride monohydrate is a potent atypical antipsychotic primarily used in the treatment of schizophrenia and bipolar disorder. This compound is recognized for its ability to effectively manage symptoms while minimizing side effects commonly associated with traditional antipsychotics. The unique structure of Ziprasidone allows it to act on multiple neurotransmitter systems, including serotonin and dopamine receptors, making it a versatile option for mental health professionals.

In clinical settings, Ziprasidone hydrochloride monohydrate has demonstrated efficacy in reducing both positive and negative symptoms of schizophrenia, providing a comprehensive approach to patient care. Its favorable pharmacokinetic profile, including a lower risk of weight gain compared to other antipsychotics, enhances its appeal among healthcare providers. Additionally, ongoing research into its potential applications in treating other psychiatric disorders underscores its relevance in modern therapeutic strategies.

Número CAS
138982-67-9
Fórmula molecular
C21H21ClN4OS · HCl · H2O
Peso molecular
467.41
Número MDL
MFCD00921885
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
138982-67-9
Fórmula molecular
C21H21ClN4OS · HCl · H2O
Peso molecular
467.41
Número MDL
MFCD00921885
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Ziprasidone hydrochloride monohydrate is widely utilized in research focused on

  • Treatment of Schizophrenia: This compound is primarily used as an antipsychotic medication, helping to manage symptoms of schizophrenia effectively, which can enhance the quality of life for patients.
  • Bipolar Disorder Management: It is also prescribed for treating acute manic or mixed episodes associated with bipolar disorder, providing stability for individuals facing mood fluctuations.
  • Research in Neuropharmacology: Researchers study its mechanisms of action to better understand how it affects neurotransmitter systems, contributing to the development of new psychiatric medications.
  • Formulation Development: Pharmaceutical companies utilize ziprasidone hydrochloride monohydrate in developing various dosage forms, including oral capsules and injectable solutions, ensuring versatility in patient treatment options.
  • Comparative Effectiveness Studies: It serves as a benchmark in studies comparing the efficacy and safety of newer antipsychotic agents, helping clinicians make informed treatment decisions.

Citas